Oncologix Tech Inc (OCLG)

[JackStraw]

Oncologix Tech Acquires Esteemcare and Affordable Medical; Gains Strong Home Medical Company

Oct 02, 2014 (eTeligis.com via COMTEX) -- ALEXANDRIA, LA, United States, via ETELIGIS INC., 10/02/2014 - - Oncologix Tech Inc. (OTC PINK: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating businesses units in medical device, healthcare services and medical products and technologies, announces the purchase of Esteemcare Inc. ("Esteemcare") and Affordable Medical Equipment Solutions Inc. ("Affordable Medical"), two companies in the medical products industry.
Wayne Erwin, OCLG's Chief Executive Officer, remarked, "Oncologix is extremely delighted to complete the acquisition of Esteemcare and Affordable. Both companies are strong distributors of home medical equipment in respiratory and sleep therapy."

Esteemcare and Affordable Medical's mission is to meet the customer needs by the delivery of high quality, cost effective, CPAP products and services. The Company has a diverse payer mix, is accredited by the Joint Commission on Healthcare Organizations and a winner of 45 Medicare Competitive Bids for CPAP and related supplies. Esteemcare and Affordable Medical began its operations in 2003 and have office locations in both Columbia and Charleston South Carolina.

Mr. Erwin further added that, "With $2.5 million in annual revenues and with over 45 additional MSA markets awarded for sales and distribution, the company is uniquely positioned for rapid growth and expansion. These acquisitions are the first of several we intend to close within the next four months continuing our expansion and growth strategy in our medical products and technologies division."

About Oncologix Tech

Oncologix is a diversified medical holding company that operates and manufactures Class II medical device products, delivers Personal Healthcare Services, and provides sales and distribution of durable and home medical products. For its clients, Oncologix provides FDA approved medical devices, state licensed healthcare services, and medical products and technologies. For its shareholders, Oncologix operates profitable business divisions that build, maintain and nourish shareholder value. The Company's corporate mission is to be the best small cap medical device and healthcare services holding company in North America.

Forward-Looking S tatements

This press release may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Company's expectations, among other things, are dependent upon economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, its ability to operate its subsidiary companies effectively, need for and availability of more capital as well as other uncontrollable or unknown factors which are more fully disclosed in the Company's filings with the Securities and Exchange Commission.

Contact:

Wayne Erwin, Chairman and CEO

[e-mail]

[phone]

SOURCE: Oncologix Tech Inc.

Associated Documentation:

http://www.eteligis.com/ViewSubmission.aspx?submissionRequest=28003 - Link to submission on http://www.eteligis.com

http://www.eteligis.com/FileHandler.aspx?submissionRequest=28003&documentRequest=18395 - OCLG_10-2-2014_PAP_ETL.doc